UBS Raises Price Target on Dentsply Int'l (XRAY) to $67; Reiterates Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Dentsply Int'l (XRAY) Tops Q3 EPS by 3c; Boosts FY16 EPS Outlook
November 4, 2016 6:40 AM EDTDentsply Int'l (NASDAQ: XRAY) reported Q3 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $954.2 million versus the consensus estimate of $967.68 million.
GUIDANCE:
Dentsply Int'l sees FY2016 EPS of $2.75 - $2.80, versus the consensus of... More
